Clinical Exercise Physiologist working in Cardiovascular Rehabilitation, interested in Fuel Metabolism, Exercise Science and Preventing Metabolic Syndrome.
This is f*cking insane. SpaceXAI engineer Lauren Tan (ex-Cursor):
"99% of people use GrokBot for 1% of what it can do. They run one agent without /loops + /graphs
I run a team of 65+ GrokBot agents. By 9 a.m. my Chief of Staff has the day planned, my PM has handed out the work, and the workers have shipped half of it"
In this 1-hour session, SpaceXAI engineer shows how to build that team from scratch
GrokBot → Chief of Staff → PM → Workers → /Loops → Self-Improving Team
A /loop sends every task back until it actually works
A /graph lets one agent hand its result to the next without you in the middle
Anyone can ask GrokBot a question, almost nobody gives it a team to run
Worth more than most $2250 agentic engineering courses
Watch it today
Then read the article below on building your own self-improving GrokBot system ↓
💊 Can SGLT2 inhibitors improve outcomes in transthyretin cardiac #Amyloidosis?
A #JACCAdvances meta-analysis of 14 observational studies (n=10,852) found #SGLT2i use was associated with 56% lower all-cause mortality & 38% lower HF hospitalization.
https://t.co/PwRd726Flu
The updated 2026 ACC Expert Consensus Decision Pathway for the Management of #HFpEF reflects a significant evolution in how HFpEF is understood and treated.
Read the full document in #JACC ➡️ https://t.co/OcXbv7ZwIi #CardioX
⚠️ Prediabetes is not a waiting room for T2D — it’s an intervention window.
The 2026 AACE Prediabetes Algorithm makes the roadmap clear.
Diagnose it:
▸ A1C 5.7–6.4% | IFG 100–125 mg/dL | IGT 140–199 mg/dL | MetS
Goals go beyond glucose:
▸ Prevent T2D & MASLD progression
▸ Reduce ASCVD risk
▸ Promote weight loss & quality of life
Overweight/Obesity present?
▸ Target >7–10% weight loss
▸ ASCVD or MASLD → Semaglutide
▸ OSA → Tirzepatide
▸ GIP/GLP-1 RA or Phentermine/Topiramate ER if no comorbidities
▸ BMI ≥40 (or ≥35 + complications) → Consider bariatric surgery
No obesity?
▸ Metformin | Pioglitazone | Acarbose to delay progression
▸ Persistent dysglycemia or overt diabetes → escalate
💡 Lean prediabetes? Don’t forget to screen for Stage 2 T1D and other diabetes types.
Lifestyle first. Always. But don’t wait to layer in pharmacotherapy when it’s warranted. 🏃♂️💊
#Prediabetes #Diabetes #GLP1 #Obesity #AACE2026 #Endocrinology #MedEd #PreventT2D
Instead of watching an hour of Netflix, watch this 1 hour Yale lecture. It will teach you more about options trading and the exact models hedge funds use than most people learn in their entire careers on Wall Street.
Coronary Artery Territories Explained
Each of the major epicardial coronary arteries supplies a specific region of the heart muscle. During an ultrasound (echo) exam, these regions can be mapped to assess myocardial perfusion and wall motion.
To standardize interpretation, the left ventricle (LV) is divided along its long axis into four main walls: anterior, inferior, septal, and lateral. At the basal and midventricular levels, both the septal and lateral walls are further split into anterior and inferior segments.
Across short-axis views, each wall is subdivided into three levels:
🔲 Basal
🔲 Mid
🔲 Apical
The very tip of the LV, beyond the cavity, forms the apical cap. In total, this creates a 17-segment model of the LV, widely used in echocardiography for assessing wall motion and perfusion.
Coronary Supply
Most of the heart's blood supply comes from the left main coronary artery, which branches into:
1️⃣ The Left Anterior Descending (LAD) artery
2️⃣The Left Circumflex (LCx) artery
🔹 The LAD primarily supplies the anterior wall and the anterior two-thirds of the septum via septal branches. It also gives off diagonal branches that supply the anterolateral wall. In some individuals, a long LAD may wrap around the apex to supply part of the inferior wall.
🔹 The LCx runs along the atrioventricular (AV) groove and gives off obtuse marginal branches that supply the inferolateral wall.
🔹 The Right Coronary Artery (RCA) supplies the inferior one-third of the septum, the inferior wall, and also provides blood to the right ventricle.
This structured layout helps echo readers correlate coronary anatomy with the 17 LV segments, essential for diagnosing regional ischemia or infarction.
Read it. Save it. Share it
@TrackYourHeart
SAVE THE DATE 📅🎉
We're 1 month away from the 2025 Phoenix Heart Walk! Join us Saturday, March 29th at the Wesley Bolin Memoirla Plaza and walk with us to save lives!
Learn more & register: https://t.co/iOi15s1Jop
LONG LIPID TWEET - Many have long known that carriers of E4 alleles who typically have increased LDL-C (apoB) and CV risk are often hypo-responders to statins. The opposite is true of E2 carriers (low absorption). The reasons are (1) E4 carriers hyperabsorb cholesterol as chylos trafficking the absorbed cholesterol carry copies of E4 which have high affinity to bind to hepatic LRP (LDL receptor related protein) and the rapid clearance increases the hepatic pool of cholesterol which in turn down-regulates LDL receptors thereby diminishing LDL clearance from plasma (increasing apoB), as well as decreasing cholesterol synthesis, indicated in graphic by lower lathosterol levels and hence hypo-response to statins (2) the hyperabsorption lessens the need for bile acids (which in homeostatic fashion would help lessen further absorption), which reduces BA production. Ezetimibe (alone or if needed in combo with low dose statin) is the way to address the hyperbetalipoproteinemia of E4's @nationallipid@society_eas@escardio@atherosociety@FamilyHeartFdn@fhpatienteurope@foundationofnla
@DrMarthaGulati @SmidtHeart @CedarsSinaiMed @WomensHeartCS This is an incredible display of appreciation for those on the frontlines of cardiac rehabilitation. You are an amazing leader and I find you so inspiring @DrMarthaGulati !
Deeply honored to receive the ISPRM Distinguished Researcher Award - Early Career 🌟 This recognition would not have been possible without the support of my mentors, colleagues, and family. Thank you to @ISPRM and everyone who is a part of this journey 💖
It was a pleasure to participate as a speaker in yesterday's webinar about #cardiac#rehabilitation hosted by @ESPRM_ I had the honor of sharing the stage with 🔝 experts in CR 🌟 We received very positive feedback, which is truly encouraging. Thank you everyone who joined us!